Director, Clinical and Translational Development
Natera- Full Time
- Senior (5 to 8 years)
Abata Therapeutics
Candidates should possess a Ph.D. or M.D. in dermatology, immunology, or a related scientific field, with a strong understanding of dermatological conditions and treatment strategies. Demonstrated experience in clinical development, particularly in later-stage clinical trials (Phase 2 and beyond), is required. Expertise in dermatology and/or immunology is essential, along with effective collaborative skills and experience working across various phases of clinical development.
As the Therapeutic Area Head - Clinical Development, you will lead and mentor a team of Medical Directors and Clinical Scientists, developing and executing an integrated clinical development strategy and clinical trial programs in dermatology. You will provide clinical expertise, obtain scientific advisory input, work cross-functionally to develop clinical studies, lead clinical aspects of regulatory interactions, and partner with the clinical operations team. Additionally, you will oversee programs across the dermatology portfolio, build relationships with investigators, contribute to the scientific communication strategy, and participate in medical review of adverse events.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.